IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

NEA Management Company, LLC

Q1 2026 Holdings

Filed 2026-05-15 | 26 holdings | $1.8B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arcellx, Inc.(ACLX)COMMON STOCK03940C100$349.7M3,045,26219.9%
Celcuity Inc.(CELC)COM15102K100$260.9M2,285,56114.8%
Spyglass Pharma, Inc.(SGP)COM SHS85220G109$191.5M7,392,30110.9%
Trevi Therapeutics, Inc.(TRVI)COM89532M101$157.7M13,222,2289.0%
Savara, Inc.(SVRA)COM805111101$133.6M24,471,2647.6%
Monte Rosa Therapeutics, Inc.(GLUE)COM61225M102$126.5M7,692,2987.2%
MBX Biosciences, Inc.(MBX)COM55287L101$107.9M3,614,4866.1%
Zenas BioPharma, Inc.(ZBIO)COM98937L105$78.7M4,023,2194.5%
Coursera, Inc.(COUR)COM22266M104$74.9M12,867,7694.3%
Aurinia Pharmaceuticals, Inc.(AUPH)COM05156V102$58.8M3,969,8343.3%
Oric Pharmaceuticals, Inc.(ORIC)COM68622P109$52.2M4,118,6213.0%
Crispr Therapeutics AG(CRSP)NAMEN AKTH17182108$50.4M1,058,5702.9%
Phathom Pharmaceuticals, Inc.(PHAT)COM71722W107$21.8M1,960,1691.2%
CVRx, Inc.(CVRX)COM126638105$19.2M2,026,0831.1%
Korro Bio, Inc.(KRRO)COM500946108$14.7M1,297,8930.8%
X4 Pharmaceuticals, Inc.(ASNSUSD)COM98420X103$13.4M3,233,7430.8%
Champions Oncology, Inc.(CSBR)COM NEW15870P307$9.9M1,713,7200.6%
Black Diamond Therapeutics, Inc.(BDTX)COM09203E105$9.5M4,448,7570.5%
Inventiva SA(IVA)ADS46124U107$8.0M1,462,5860.5%
Nkarta, Inc.(NKTX)COM65487U108$7.5M3,568,7810.4%
LeonaBio, Inc.(LONA)COM04746L203$4.8M464,3980.3%
Senti Biosciences, Inc.(SNTI)COM NEW81726A209$3.1M3,775,6150.2%
Marker Therapeutics, Inc.(MRKR)COM NEW57055L206$2.1M1,625,6780.1%
OnKure Therapeutics, Inc.(OKUR)COM CL A68277Q105$2.0M478,5480.1%
Gossamer Bio, Inc.(GOSS)COM38341P102$328.5K1,000,0000.0%
ImageneBio, Inc.(IMA)COM45175G207$250.0K50,0050.0%